Criteria not met: The American Thoracic Society suggests weekly augmentation therapy with human pooled AAT for individuals who have plasma levels of AAT less than 11 µmol/L and established airflow obstruction, defined as an FEV1.
Answered 10/20/2014
3.6k views
A doctor has provided 1 answer
5 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question